Chemosensor receptors are lipid-detecting regulators of macrophage function in cancer
Authors:
Open Access
- 30 June 2025
- journal article
- research article
- Published by Springer Nature in Nature Immunology
- Vol. 26 (7) , 1182-1197
Abstract
Infiltration of macrophages into tumors is a hallmark of cancer progression, and re-educating tumor-associated macrophages (TAMs) toward an antitumor status is a promising immunotherapy strategy. However, the mechanisms through which cancer cells affect macrophage education are unclear, limiting the therapeutic potential of this approach. Here we conducted an unbiased genome-wide CRISPR screen of primary macrophages. Our study confirms the function of known regulators in TAM responses and reveals new insights into the behavior of these cells. We identify olfactory and vomeronasal receptors, or chemosensors, as important drivers of a tumor-supportive macrophage phenotype across multiple cancers. In vivo deletion of selected chemosensors in TAMs resulted in cancer regression and increased infiltration of tumor-reactive CD8+ T cells. In human prostate cancer tissues, palmitic acid bound to olfactory receptor 51E2 (OR51E2) expressed by TAMs, enhancing their protumor phenotype. Spatial lipidomics analysis further confirmed the presence of palmitic acid in close proximity to TAMs in prostate cancer, supporting the function of this lipid mediator in the tumor microenvironment. Overall, these data implicate chemosensors in macrophage sensing of the lipid-enriched milieu and highlight these receptors as possible therapeutic targets for enhancing antitumor immunity.Keywords
This publication has 43 references indexed in Scilit:
- A new era of macrophage-based cell therapyExperimental & Molecular Medicine, 2023
- Genome-wide CRISPR screens of T cell exhaustion identify chromatin remodeling factors that limit T cell persistenceCancer Cell, 2022
- Ectopically expressed olfactory receptors OR51E1 and OR51E2 suppress proliferation and promote cell death in a prostate cancer cell lineJournal of Biological Chemistry, 2021
- High-Throughput CRISPR Screening Identifies Genes Involved in Macrophage Viability and Inflammatory PathwaysCell Reports, 2020
- Greasing the Wheels of the Cancer Machine: The Role of Lipid Metabolism in CancerCell Metabolism, 2020
- Pexidartinib versus placebo for advanced tenosynovial giant cell tumour (ENLIVEN): a randomised phase 3 trialThe Lancet, 2019
- Genome-wide CRISPR Screens in Primary Human T Cells Reveal Key Regulators of Immune FunctionCell, 2018
- A Genome-wide CRISPR Screen in Primary Immune Cells to Dissect Regulatory NetworksCell, 2015
- The prostate‐specific G‐protein coupled receptors PSGR and PSGR2 are prostate cancer biomarkers that are complementary to α‐methylacyl‐CoA racemaseThe Prostate, 2006
- The olfactory receptor gene superfamily of the mouseNature Neuroscience, 2002